XNYS · CBRE
+0.92% · +$1.19 · Vol 577.4K
Live · updated 11:52:59 ET
CBRE GROUP, INC.

CBRE GROUP, INC.

REAL ESTATE
$131.72
Card
Relationship Map

Follow $CBRE

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $CBRE by email

Veridion Score

BETAMEDIUM CONF · 6 of 6 factors measuredMethodology
CBRE
CBRE GROUP, INC.
Thu Oct 1 · last completed session · daily score · 18h old
Upper range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

64/ 100
Veridion Score
Upper range · MEDIUM confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: MEDIUM · 6 of 6 factors measured · Thu Oct 1 · last completed session · daily score · 18h old
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is CBRE moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading CBRE catalysts
About CBRE GROUP, INC.
REAL ESTATE
Listed since
2004
Employees
155K
Country
US

CBRE is the world's largest commercial real estate services and investment firm, providing brokerage, leasing, facilities and project management, valuation, mortgage services, and investment management to occupiers and investors across every major property type. The firm in its current form traces its lineage to a 1998 merger of CB Commercial with UK-based Richard Ellis International, whose own history goes back to London in the 1770s. Today, CBRE employs more than 140,000 people serving clients across more than 250 markets in over 100 countries.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$132.52
Day high
$134.52
Day low
$131.46
Previous close
$130.53
52W high
$171.61
-23.24% from high
52W low
$124.64
15% of range
Market cap
$37.8B
Beta
0.59
Shares out
289.6M
Volume
577.4K
0.31× rel vol
Avg volume
1.9M
VWAP
$132.71
Price history computed in-house
1W
-2.10%
1M
-7.28%
3M
-6.96%
1Y
-15.36%
YTD
-18.08%
SMA 50 $144.12 · below
SMA 200 $145.30 · below
52W position 15%

CBRE overview

Loading financial statements
Loading CBRE Form 4 filings
Public disclosures

Congress activity in CBRE

Susie LeeSelljoint

CBRE group Inc Common Stock Class A · Transaction Jul 29, 2020 · Filed Sep 3, 2020 · $1,001 to $15,000

Official filing ↗
Susie LeeSelljoint

CBRE group Inc Common Stock Class A · Transaction Apr 3, 2020 · Filed Jun 15, 2020 · $1,001 to $15,000

Official filing ↗
Susie LeeSelljoint

CBRE group Inc Common Stock Class a · Transaction Mar 18, 2020 · Filed Apr 28, 2020 · $1,001 to $15,000

Official filing ↗
Susie LeeSelljoint

CBRE group Inc Common Stock Class a · Transaction Aug 29, 2019 · Filed Sep 30, 2019 · $1,001 to $15,000

Official filing ↗
Susie LeeBuyjoint

CBRE group Inc Common Stock Class a · Transaction Apr 25, 2019 · Filed May 9, 2019 · $1,001 to $15,000

Official filing ↗
Federal contracts

CBRE contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CBRE in this window.
Lobbying spend

CBRE lobbying filings, year to date.

Registered lobbying filings matched to CBRE GROUP, INC..

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for CBRE in this window.
Loading news for CBRE
Analyst ratings
Sovereign unlock shows live analyst consensus for CBRE.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.